The symposium for key enterprises in the big health industry of Tianjin High-tech Zone and the signing ceremony for the establishment of Chuangyuan Biotech's special medical food project was a complete success.

(Han Lin, Standing Committee Member of the Tianjin Binhai High-tech Zone Party Committee and Deputy Director of the Management Committee, delivered a speech)

On the afternoon of May 21, the symposium for key enterprises in the health industry of Tianjin High-tech Zone and the signing ceremony for the establishment of the special medical food project by Chuangyuan Biotechnology Co., Ltd. was held at Tianjin Chuangyuan Biotechnology Co., Ltd. Han Lin, Standing Committee Member of the Tianjin Binhai High-tech Zone Party Committee and Deputy Director of the Management Committee, Jia Peng, Executive Deputy General Manager of Tianjin Institute of Pharmaceutical Research, Luo Xuegang, Dean of the School of Bioengineering at Tianjin University of Science and Technology, Sui Wenjie, Associate Professor at the School of Food Science and Engineering at Tianjin Agricultural University, Liu Qingfen, Director of the Industry Department of the Institute of Radiation Medicine, Chinese Academy of Medical Sciences, relevant responsible comrades from the Business Promotion Bureau, Biomedicine Bureau, Free Trade Bureau, State-owned Assets Company, and Haitai Capital of Tianjin Binhai High-tech Zone, as well as representatives from key enterprises in the health industry and investors attended the event. Liang Wu, Chairman of Chuangyuan Biotechnology, Shi Yali, Executive Vice President, and the management team participated in the symposium. The symposium and signing ceremony were hosted by Zhao Jing, Director of the Biomedicine Bureau of the High-tech Zone.

Deputy Director Han Lin pointed out that in recent years, the High-tech Zone has continuously increased its layout in the health industry. On the research and development side, Chuangyuan Biotechnology has been approved to establish a key laboratory for edible probiotics in Tianjin. On the industrial side, the High-tech Zone has laid out the entire industrial chain of health food in upstream raw material supply, midstream product production, and downstream sales applications, gathering a number of key enterprises in health food and special dietary food. This strong cooperation between Chuangyuan Biotechnology and the Pharmaceutical Research Institute will further complement the special medical food sector in the High-tech Zone's layout of the health industry.

(Liang Wu, Chairman of Chuangyuan Biotechnology Co., Ltd., delivered a speech)

Liang Wu, Chairman of Chuangyuan Biotechnology, stated that Chuangyuan Biotechnology settled in the High-tech Zone in 2018 and has deeply felt and experienced the High-tech Zone Management Committee's 'high position, strong awareness, good policies, and broad resources,' providing multi-faceted support for enterprises in terms of policies, funds, talents, and resources. This cooperation with the Tianjin Institute of Pharmaceutical Research is another important strategic layout in the process of enterprise development. Both parties will closely combine national advantageous scientific and technological forces with strong industrial strength, striving to create a special medical food industry cluster integrating research and development, production, and sales in the High-tech Zone within 3-5 years, serving the economic and social development of Binhai New Area, promoting coordinated development in the Beijing-Tianjin-Hebei region, and contributing more wisdom and strength to human health and well-being.

(Chuangyuan Biotechnology and the Pharmaceutical Research Institute signed a strategic cooperation agreement)

At the meeting, Chuangyuan Biotechnology and the Tianjin Institute of Pharmaceutical Research signed a strategic cooperation agreement to deepen cooperation in the field of special medical food. Liang Wu, Chairman of Chuangyuan Biotechnology, and Jia Peng, Executive Deputy General Manager of the Pharmaceutical Research Institute, signed on behalf of both parties. Deputy Director Han Lin and Dean Luo Xuegang jointly witnessed the signing ceremony.

After the signing ceremony, several experts, scholars, and leading enterprise representatives from the health industry and investment field exchanged and shared new technologies, new achievements, and new consensus, promoting cooperation in multiple areas such as production, education, research, and finance.

A delegation from Chengge Pharmaceutical Group visited Chuangyuan Biotechnology for inspection and exchange.

Chuangyuan Biotechnology made a wonderful appearance at the 2024 NHNE.

A delegation from Chengge Pharmaceutical Group visited Chuangyuan Biotechnology for inspection and exchange.

Chuangyuan Biotechnology made a wonderful appearance at the 2024 NHNE.

2024-12-23

In December 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. and Haihe Dairy jointly held a series of themed activities titled "Party Building Mutual Visits and Learning" to further promote the deep integration of both parties' party building work and business development. During the event, both sides will conduct company visits and on-site discussions. Recently, Haihe Dairy made an initial visit and, after gaining a deep understanding of Chuangyuan Biotech's products, expressed high recognition and close attention, laying a solid foundation for future cooperation. Subsequently, both parties engaged in detailed communication on the core topics of "exchange of party building experiences and sharing of business resources," discussing standardized construction of party branches, distinctive party building measures, and the promotion of party-business integration. They also conducted in-depth exchanges on aspects such as corporate cooperation, product intercommunication, and information sharing, jointly exploring new paths for the development of the health industry under the guidance of party building, providing more possibilities for further establishing a "symbiotic, mutually promoting, and win-win" cooperative relationship. Both parties hope to achieve industrial resonance through party building leadership and contribute to the development of the health industry in the Binhai New Area.

Strength crowned, Chuangyuan Biotechnology won two Science and Technology Awards from the China Food Industry Association.

2024-12-17

On December 16, 2024, the 22nd China Food Safety Conference and the 2024 National Food Industry Science and Technology Progress Conference, themed "Implementing Food Safety Strategy to Support the Construction of a Healthy China," was grandly held in Beijing. During the conference, the award ceremony for the 2024 National Food Industry Science and Technology Progress Conference was also held. Tianjin Chuangyuan Biotechnology Co., Ltd. won the second prize for scientific and technological progress in the "2023 China Food Industry Association Science and Technology Award" for two projects: "Key Technology Breakthrough and Industrial Application of New Postbiotics Segmented Solid-State Fermentation" and "Development and Application of Key Technologies and Equipment for Plant Polysaccharide Efficacy Verification and Extraction."

Chuangyuan Biotech's lactic acid bacteria IOB701 post-fermentation probiotic powder has been granted a national invention patent.

2024-12-13

On December 13, 2024, Tianjin Chuangyuan Biotechnology Co., Ltd. received an invention patent certificate from the National Intellectual Property Administration for its independently developed and filed method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder (Patent No.: ZL 202411354886.X). This invention provides a method and application for the preparation of Lactobacillus plantarum IOB701 fermented postbiotics powder, which relates to the field of microbiology. The Lactobacillus plantarum IOB701 was preserved on July 10, 2018, at the General Microbial Culture Collection Center of the China Microbial Strain Preservation Management Committee, abbreviated as CGMCC, with the preservation address at No. 3, Courtyard 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number CGMCC No. 16077. Using grains or legumes treated with low oxygen stress as the fermentation substrate, the Lactobacillus plantarum IOB701 fermentation resulted in postbiotics powder, which, according to animal experiments, has been shown to improve chronic unpredictable mild stress-induced depressive-like behavior in mice.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Jin Gong Wang An Bei No. 12019202000539

Business License